1 / 18

Silent Voice Survey A survey of prostate cancer patients in Europe

Silent Voice Survey A survey of prostate cancer patients in Europe. OVERVIEW OF RESULTS. Patient demographics. Number of patients and age. Healthcare professional most involved in patient treatment and management following diagnosis. Treatment course undertaken following diagnosis.

cybele
Télécharger la présentation

Silent Voice Survey A survey of prostate cancer patients in Europe

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Silent Voice Survey A survey of prostate cancer patients in Europe OVERVIEW OF RESULTS

  2. Patient demographics

  3. Number of patients and age

  4. Healthcare professional mostinvolved in patient treatment and management following diagnosis

  5. Treatment course undertaken following diagnosis

  6. How are prostate cancer patients accessing information about their condition?

  7. MAIN SURVEY JUNE 2009 Did patients receive information about prostate cancer at diagnosis? Q: When you were first diagnosed with prostate cancer were you given any information concerning this condition? Base: All respondents (Total=252/France=50/Germany=50/Italy=50/Spain=50/Poland=52)

  8. MAIN SURVEY JUNE 2009 How informative was the information patients were given about prostate cancer? Q: On a scale of 1 to 4, please rate the information you were given, upon being initially diagnosed with prostate cancer, for each of the following aspects? - Explanation of your condition Base: All who were given any information concerning prostate cancer when first diagnosed (Total=201/France=33/Germany=34/Italy=43/Spain=45/Poland=46)

  9. MAIN SURVEY JUNE 2009 How informative was the information patients were given about the likely outcome of their diagnosis? Q: On a scale of 1 to 4, where 1 is 'Not at all informative' and 4 is 'very informative', please rate the information you were given, upon being initially diagnosed with prostate cancer, for each of the following aspects?- Explanation of the likely outcome Base: All who were given any information concerning prostate cancer when first diagnosed (Total=201/France=33/Germany=34/Italy=43/Spain=45/Poland=46)

  10. MAIN SURVEY JUNE 2009 How informative was the information patients were given about their treatment options? Q: On a scale of 1 to 4, where 1 is 'Not at all informative' and 4 is 'very informative', please rate the information you were given, upon being initially diagnosed with prostate cancer, for each of the following aspects? - Explanation of your treatment options Base: All who were given any information concerning prostate cancer when first diagnosed (Total=201/France=33/Germany=34/Italy=43/Spain=45/Poland=46)

  11. MAIN SURVEY JUNE 2009 Which information sources did patients find most useful following diagnosis? Q: Following your initial diagnosis of prostate cancer, which ONE of the following sources of information did you find most useful? Base: All respondents (Total=252/France=50/Germany=50/Italy=50/Spain=50/Poland=52)

  12. What is important to prostate cancer patients when making decisions about their treatment options?

  13. MAIN SURVEY JUNE 2009 How do patients prefer treatment decisions to be made? Q: Which ONE of the following options best describes how you would prefer your doctor to approach treatment decisions with you? Base: All respondents (Total=252/France=50/Germany=50/Italy=50/Spain=50/Poland=52)

  14. MAIN SURVEY JUNE 2009 How informed do patients feel about their treatment options? Q: With regard to the treatment options you were given, which one of the following options best describes how informed you felt? Base: All respondents (Total=252/France=50/Germany=50/Italy=50/Spain=50/Poland=52)

  15. MAIN SURVEY JUNE 2009 What other factors are important to patients when making treatment decisions? Q: Aside from the effectiveness of your treatment, please rank, in order of their importance to you, the following factors that you feel your doctor should take into account when making treatment decisions. Base: All respondents (Total=252/France=50/Germany=50/Italy=50/Spain=50/Poland=52)

  16. MAIN SURVEY JUNE 2009 If impact on lifestyle is important to patients, have they discussed this with their physician? Q: Having ranked 'impact on lifestyle' as the most important consideration your physician should take into account (aside from the effectiveness of the treatment), have you discussed this with him/her? Base: All respondents who ranked 'impact on your lifestyle' as the most important factor in their treatment decision (Total=102/France=8/Germany=30/Italy=28/Spain=16/Poland=20)

  17. MAIN SURVEY JUNE 2009 Why haven’t some patients discussed impact on lifestyle with their physician? Q: What has held you back from discussing the potential impact your treatment may have on your lifestyle? Base: All respondents who ranked 'impact on your lifestyle' as the most important factor in their treatment decision but did not discuss this with their physician (Total=31/France=2/Germany=12/Italy=3/Spain=5/Poland=9)

  18. MAIN SURVEY JUNE 2009 What is most important to prostate cancer patients following diagnosis? Q: Having been diagnosed with prostate cancer, please rank, in order of their importance to you, the following four options. Base: All respondents (Total=252/France=50/Germany=50/Italy=50/Spain=50/Poland=52)

More Related